Nuclear Structure and Function Overview
Nuclear Structure and Function Overview
The transcription:
By using fluorescent dyes which has uridine as a couple system. The uridine can send from DNA to RNA
then the labeled uridines’ pulses only can be seen in the short time, after washing and analyzing how
many dots were observed. In sum up:
➢ By fluorescence uracil (Fl-U): transcription foci (5000 ~ 10000) = polymerase spackles.
➢ By bromo-domain uracil (Br-dU): replication foci (1000) = in the S-phase, in the spackles.
➢ By γ-H2AX: repair (radiation and) = 20 ~ 50.
PML bodies:
The PML bodies are a few sides, inside the nucleus. The name is derived from Pro Myelocytic Leukemia
bodies. These bodies were isolated, tagged by fluorescent. The analyzed data show the PMLs are
responsible for:
• Antiviruses
• Apoptosis
• DNA damage
• Cellular senescence
• Proteolysis
• Gene regulation (as much as suppression)
The mechanism for activation or suppression is not clear but regarding the structure, it’s known the
PML bodies within the situation, they can release or recruit a mechanism that affect by its sides.
Transcription factories (hubs, nuclear factories):
The nuclear factories are highly active transcription sites and inside the nucleus which can involve into
the many genes’ transcription that need be co-transcribed. The RNA Pol II can conglomerate with
different factors and proteins. Usually, transcription factories can cause chromatin loop formation. The
DNA is looping into these spackles and transcription factories. For example, Hbb (hemoglobin) and Klf1
and Hba genes are co-transcribed at the same time, and these genes are from different chromosomes.
In the transcription factories, the RNA Pol II has a carboxyl terminal domain can be phosphorylated
and for antibody experiments are useful. The specific antibodies can bind in the active form during
phosphorylation. Then the results show:
➢ RNA Pol II antibody staining: locations of RNA Pol II active sites.
➢ BrUTP incorporation: BrUTP antibody staining
Structure of a transcription factory:
The RNA Pol II in the transcription factory, DNA loops into that and RNA will be synthesized. Due to the
transcription factories are unlikely to move, because of looping into that, probability they are linking
systems, DNA moves into and out of the transcription factory to produce RNA transcribes. The
stationary RNA Pol II molecules could reel the transcribed DNA through the factory. Also, beside the
transcription factories, there are some organizer factories where they have transcription occurring,
looping, and enhancer interaction with the promoter. The intergenic transcription that probably is
much more complicated. Then, the organizer factories that allow transcription with the interaction of
enhancers, silencers, and promoters. But also, CTCFs and boundary terminators are not to providing.
Colocalization:
Basically, it suggests that gene colocalization is in the nucleus. This colocalization is for gene expression
and co-regulation. There is a chromosome territory and looping sites of active gene transcription at
the active compartment.
Summary: organization of eukaryotic genome:
The DNA is a double helix but not naked. It is associated with core histones. Then each nucleosome
(core histones + DNA) forms chromatin fibers. Then chromatin fibers can be magnified to the
chromatin loops (megabases. Kilobases). Then regarding the looping, they will become chromatin
domains. Then, chromatin compartments and finally chromatin territories will be formed. Inside the
nucleus, there are chromosomes, active and inactive compartments, lamin associated domains (TADs)
and nucleolus.
The principle of genome organization is the interplay several fundamental principles that grown on
genome organization.
1. Dynamic chromatin: chromatin is highly dynamic, and it is highly flexible system and not fixed.
2. Phase separation: heterochromatin, euchromatin (active and inactive chromatin separated).
3. Architecture elements: such as nuclear lamina, nucleolus, etc.
4. Heterogeneity and stochasticity.
5. Polymer – polymer interactions. DNA, RNA, and proteins are polymers, and they have
interactions to each other’s.
The transcription mechanism:
Activation by p300/CBA activator and co-activator molecules. They don’t bind to DNA directly, but they
can interact with transcription factors.
- Bridge between the TFs and basal machinery that RNA Pol II can bind to this bridge and can
induce a looping.
- p300 and CBA molecules can also interact with chromosome modifying enzymes like HAT
(Histone Acetyl Transferase), NAP (Nuclear Assembly Protein) that can assemble nucleosome.
This function is known as the scaffold.
- Histone modifications: adding or removing chemical radical(s) such as methylation,
acetylation, etc. Histone acetylation can activate gene expression locally.
- DNA binding TFs can be classified as: “Transcription activator” and “Transcription repressor”.
As a transcription activator, Jun and Fos that are heterodimer and also known as “proto-
oncogenes”. Usually, both proteins are overexpressed in the cancers. They have interaction
sites for DNA composed with the basic area of amino acids (basic amino acids can interact with
acidic backbones of DNA, phosphatic parts). In addition, they have zipper that such as a real
zipper can stabilize heterodimer in leucin as hydrophobic parts. Therefore, leucin – leucin
zipper together led to stabilize heterodimer complex DNA.
- TATA-Box Binding Protein (TBP) is another important factor for transcription. This monomeric
factor can bind to DNA and will recruit a signal for other TBP interacting factors, and RNA Pol
II will bind to the site and start transcription. Also, TBP alters genes are turned on or expressed.
The nuclear hormone receptors:
The glucocorticoid receptors are classified as the nuclear hormone receptors with the zinc finger for
DNA binding domains. The zinc atoms at the Zinc-Finger DNA binding domains, can stabilize the alpha
helix which is recognizing DNA sequence on the DNA. The glucocorticoid receptor binds to
glucocorticoid hormones in the hormone suppression, such as cortisol. The binding mechanism is
known as “homodimer”.
- Zinc-Finger is a homodimer and glucocorticoid receptor. It leads to the DNA transcription via
the factor – DNA interaction.
- Jun and Fos (=AP1) are heterodimer and known as basic leucin zipper.
- TBP is working for both groups.
The nuclear organization:
For gene regulation, it is not enough to have enhancers, promoters, silencers, and TFs. It needs
organization of TADs, looping, CTCFs and insulators.
- Insulators such as CTCFs have cohesin and condensin that can stabilize DNA looping and have
poly-com proteins (PCs) and TFs interactions.
- CTCFs insulator and TFIIIC insulator are known in mammalians. However, fruit flies have more
insulators such as dCDCF (Drosophila CTC- binding factor) insulators, GAGA insulators, etc. The
reason for being more insulators in fruit flies is the genome size that is smaller. Therefore, the
genes are located closely to each other. To promote the correct expression in development or
the tissue specific expression, or the time-depending expression, it is important to insulate
genes, then regarding the insulators and tightly genes’ localization, they have more insulators.
- The nuclear organization is related to the gene expression. A looping can have a couple of
genes and CTCFs can allow to express gene or not. The CTCF can by insulating cause expression
or suppression. However, both mechanisms caused by histone marks.
- Today’s technology let us detect close location, cross, and analyzing insulators, CTCFs also,
close-related promoter and enhancer to the gene.
- Taking count of looping that some enhancers are very far away still cannot loop into close
promoter destiny or proximity. Also, too many loops are colocalized and having coexpression
system that interact either with CTCF bodies, polyCom bodies, and looping outside and inside
of coexpression. The chromosome takes compact structure or linear with or without loops. It
can have linker sequence to chromatin.
Superenhancers:
Beside of normal enhancers, other class that called “superenhancers”. The difference is the size,
normal enhancers are between 200 bp to 1 kb, and many have binding factors. However,
superenhancers are bigger (between 10 to 15 times larger) than the average and limited by genome.
It seems that superenhancers are very important for developmental aspects and differentiation
processes. Genes that are regulated by superenhancers could be found in stem cells for developmental
aspects. However, regular enhancers can just regulate one or few genes.
Due to the superenhacner’s size, they have more binding sites rather than normal one. It seems to
different cellular system, they involve into the different processes and side effects, e.g., stem-cellness
or stemness is proofed by Oct4, Sox2, Nanog, KII4 and Errb pathways that can bind to the same
superenhancer can control stemness and genes’ expression.
Nucleosome positioning:
It seems that nucleosome free sites are enhancers, around transcription start sites, also termination
sites. The high nucleosome positioning alters the first nucleosome of starting transcriptional site. For
example, in the one steady on Saccharomyces cerevisiae the nucleosome free positioning could be
found around the (before) termination site.
Controlling of gene expression:
The controlling can be possible via these ways:
- Transcription rate controlling of how many per time is produced: mRNA, tRNA, rRNA, long non-
coding RNA, micro-RNA.
- Promoting, inhibition of transcription initiation complex.
- At the level of DNA methylation and epigenetic silencing.
- Recruiting of remodeling and mediator complexes.
- Binding of transcriptional activators/ repressors to enhance/ silence the elements.
- Opening/ repression of chromatin accessibility (nucleosome assembly, remodeling, histone
exchange, histone modifications).
- Localization within the nuclear structures.
- Allowing DNA looping.
Transcriptional Regulation of RNA Pol II promoter:
There are three of RNA Polymerase (RNAP) in the eukaryotes:
1. RNA Polymerase I (RNAPI)
2. RNA Polymerase II (RNAPII)
3. RNA Polymerase III (RNAPIII)
The RNAPI is a polymerase that can transcribe the coding of protein genes. Although the amount of
coding proteins in the genome is very low, many experiments have been shown towards analysis this
RNAP promoters. Since proteins are major parts of regulatory pathways and phenotypes.
The structure of RNAPII promoters contains: (a) transcription start site which defines as “+1”, (b) the
upstream of this start site in about 40 ~ 45% of all genes is “TATA-Box” (not all genes!), then (c)
different promoter elements that are upstream of TATA-Box.
For initiation of transcription is opening chromatin, then allowing the first factor binds to the TATA-
Box is “TBP” (TATA-Box Binding Protein). The TBP can bind too much to the DNA, also TBP can bind
with “TFIID” complex. The TF IID has several subunits. After TF IID binding, other TFII molecules will be
recruited such as “TFIIA”, “TFIIB”. then, RNA Pol II can be bound via “TFIIE”, “TFIIF” and “TFIIH” to the
chromatin. (Chromatin (TATA-box) + TBP > + TFIID > + TFIIA, + TFIIB> +TFIIE, +TFIIF, +TFIIH > RNAPII
binding)
RNAPII never binds directly to DNA; it binds to the factors that are bound to the promoter. This is
different rather than prokaryotes. Then, RNAPII needs phosphorylation for activation of RNA
polymerization.
The Promoter and RNAPIIs:
Each promoter has different parts such as “regulatory promoter” and “core promoter”. The core
promoter contains:
- The TATA-box is located around “-25 bp”.
- The TFIIB recognition element site around “-35 bp”.
- Initiator element site at “+1 bp”.
- Downstream Core Promoter element around “+30 bp”.
Some genes do not have TATA-box then the inhibition element that is around the transcription start
site (TSS), sometimes exists at downstream of core promoter. Each elements plays an important role
e.g., TBP at the initiation level that TFIIA binds to it and recruits other TFII elements. In the end, there
are a core promoter which can initiate RNA polymerization as a protein complex that includes TFIIB,
TFIID, TFIIE, TFIIF, TFIIH and RNAPII called RNAPII holoenzyme. The key factors are TBP and TATA-box
complex that can bind directly or indirectly via TFIIA.
The recruitment rate is regulated by initiation activity of RNAP. Also, the regulation is happened by
other DNA elements like silencers, enhancers, that can be at up-/downstream of promoter. The
enhancers can bind to the transcription activators. The silencers act as transcription repressors. These
elements can affect the promoter via looping that could be a further coregulator.
Coregulator can make mediation at the initiation level between transcription factors that bind to
regulatory elements, and the DNA up- and downstream of promoter and basic transcriptional
machinery.
A looping between transcription activators and distal sites of the promoter leave loop into the density
and proximity of promoter region. Promoter region is composed of TBP, subunits of TFIIB, RNAPII,
TFIIF, TFIIE, and TFIIH.
The transcription activator in Drosophila melanogaster is Hunch Back (HB) and Bicoids (BCD) that are
able to connect directly to TFIID subunits. By recruiting these TFIID subunits, the recruitment of TFIID
complex is much faster because the high affinity of promoter, therefore the transcription rate is faster.
Transcriptional regulation of RNAPII promoters:
The regulation has a reputation from the elements, and different stepwise recruitments of the big
protein complex. TBP is one of the big factors that associated with the TFIID which is recruited the
TATA-box or initiator elements, around the transcription start site (TSS) to TFIIA. This initiation complex
recruits other factors like TFII protein complexes (TFIIA, TFIIB, RNA Pol II, TFIIH, TFIIF, TFIIE, and
mediator). This protein complex is now built up at around the transcription start site. Then, other
factors such as silencers can loop into it to get closer to the promoter and then regulate the
transcription activity of RNAPII. These transcription factors can either be linking there, interactions
through coregulators, coactivators, corepressors; or directly interaction with mediators or even basic
transcription machinery.
The RNAPIII promoters:
RNAPIII transcribes special RNAs that are small. They have ribo-small RNAs or 5S-rRNAs which is
generated by RNAPIII, also tRNAs, some U6-RNAs and other splicing RNAs. Promoters and other
regulatory elements play main roles for RNAPIII identification. For example, on tRNA genes, only
RNAPIII with other initiation factors can transcribe, because the promoters and up-/downstream of
gene(s) are the main identifying elements for RNAPIII activation. Similarly, for 5S-rRNA genes,
promoters lay in the gene. Then, can be identified by sequence comparison of different elements,
called “A” and “B” (and sometimes “C” also) that are recognized by proteins. Others do have TATA-
box, such as U6-RNA and another element. It is very surprising that RNAPIII doesn’t need a specific
region or sequences and it’s highly flexible.
Sum up for two main concerning of RNA Pol III: (a) concerning the location of promoters, (b) which
types of elements exist.
The factors that can binding to the promoters can be identified by three factors: (a) TFIIIB, (b) TFIIIC,
and (c) TFIIIA. The genes have internal promoter, first recruit TFIIIC, then binds to the conserve
sequencing of A and B-box, then TFIIIB recruited and finally, both recruit RNAPIII (+TFIIIC A&B-box>
+TFIIIB >> RNAPIII). Those have internal promoters but different boxes, first TFIIIC then TFIIIB and both
recruit RNAPIII (+TFIIIC > +TFIIIB >> RNAPIII). Basically, there are three major subunits of protein
complex. Those genes have external promoter of transcribing genes, some of them have TATA-box
(e.g., IIIB-like protein complex) and this recruits RNAPIII. Another scenario is TFIIIB only recruits RNAPIII
(+TFIIIB >> RNAPIII). This is a flexibility for RNAPIII to recognize and bind the promoters.
Assembly of RNAPIII and related TFs:
The recognition of TFIIIA, TFIIIB, and TFIIIC is done by many fraction assays. The 5S-rRNA gene, first by
TFIIIA is bound (a protein with many Zinc-fingers), then TFIIIC is bound and finally TFIIIB with some
subunits such as TBP (for TATA-box). Then, the RNAPIII will start transcription.
Comparing 5S-rRNA gene vs. tRNA gene:
tRNA gene contains Box A and Box B; first TFIIIC, then TFIIIB and finally RNAPIII.
5S-rRNA: gene contains Box A and Box C; first TFIIIA, then TFIIIC, third TFIIIB and finally RNAPIII.
Overview on composition of RNA Pol I, II, and III in the Pre-Initiation Complex (PIC):
- RNAPI: TFIs (SL-1) > TBP (lateral part)
- RNAPII: TFIIs > TBP (central part)
- RNAPIII (different types of promoters): Internal (or) External gene: TFIIIs > TBP (central part
and key role)
RNAPII recruitment and elongation:
The RNAPII needs to recruit and then start polymerization. The rate of recruitment controls the
expression rate. Furthermore, Pre-initiation complex (PIC) recruitment, the transcription rate also
controlled by elongation rate. Elongation rate means how fast the entire gene can be transcribed. It's
important to notice that elongation is related to the recruitment.
The RNAPII has CTD (Carboxy-Terminal Domain) that is a long tail of heptide repeats. The heptide
repeat means seven amino acids are repeated. This heptide in mammalian's CTD of RNAPII is repeated
52 times which is consistent with Tyrosine – Serine – Proline – Threonine – Serine – Proline – Serine.
If you look at this structure via biochemistry, that tyrosine, serine, and threonine have hydroxyl groups
that are very important for PIC regulation due to the final phosphorylation.
When RNAPII is recruited for PIC, then CTD is phosphorylated. The phosphorylation is happened when
RNAPII is bound to initiation complex. Also, only Ser-2 and Ser-5 are phosphorylated. Then, RNAPII
starts transcription and elongation. When, the transcription is terminated, the phosphorylated amino
acids will have dephosphorylation. The Ser-2 and Ser-5 of CTD phosphorylation are important because
they are a part of the regulatory system for controlling elongation via the affection the elongation rate.
CTD phosphorylation of RNAPII:
Regarding the experiments, if only RNAPII is recruited, there is no transcription, because the Ser-5 or
Ser-2 were not phosphorylated. If both Ser-5 and Ser-2 are phosphorylated, then the transcription
will be started. The Ser-2 and Ser-5 phosphorylation is highly limited and compressed. However, this
phosphorylation is not sufficient for elongation rate. Some of the peptides has glycosylation in their
combination. This combination allows for elongation rate; for instance, in mammals 52 repeats, in
yeasts 26 repeats are reported for heptides and it seems mammals have more sites for controlling the
phosphorylation level that which amino acids in which level is phosphorylated and then glycosylation
rate. There are many sides here to regulate the elongation rate.
Inhibition of RNAPII and RNAPIII:
• Alpha-Amanitin (α-Amanitin) is very specific inhibitor of RNAPII and RNAPIII. It is a cyclic
peptide that contains 8 amino acids. α-Amanitin is derived from a toxic fungus called Amanita
phalloides that its toxicity is caused by presenting of α-Amanitin. α-Amanitin is a lethal
compound.
• Actinomycin D is another inhibitor that prevents elongation of RNA chain by RNAPII. This
molecule is an antibiotic with three major cycles. It's important to note that Actinomycin D is
more specific rather than α-Amanitin.
Active sites of transcription:
In the nucleus there are some active sites of transcription. One uses antibody against Ser-5 or Ser-2
phosphorylation of RNAPII. These sites are loci that active transcription parts of nucleus and show as
where and the nuclear architecture of active gene transcription.
The analysis with antibodies against phospho-Ser2 will show specific loci like dots in the nucleus.
Therefore, regarding this method if Actinomycin D or α-Amanitin is used, the results will be something
else with different rates. In the α-Amanitin treatment, it's illustrated that less dots which means more
power for reducing and then major effects on RNAP inhibition.
However, Actinomycin D can inhibit less than α-Amanitin, i.e., more dots than α-Amanitin treatments.
It's also suggested that experiments showed the phosphorylation event of Ser-2 and Ser-5 in the
presence of Actinomycin D, still not sufficient to explain a very good elongation rate. But it suggests
that some sites are active, and their elongation rate will not be possible due to the additional steps
that will need to be phosphorylation.
Regulation of gene expression:
At the RNA level:
- mRNA stability/ degradation
- splicing
- Editing
- Export / Import to the cytoplasm/ nucleus
- Binding to ribosome/ efficacy of translation (miRNAs)
Splicing:
The term of splicing basically means to remove “introns” of pre-mature mRNA that was transcribed
form gene(s) and then fusing the “exons” together to generate a normal mRNA. The mRNA will not be
matured after splicing, it needs to add 5’-end capping and 3’-end tailing (Poly-adenine tail: ~ 100 – 300
adenines) to obtain the mature mRNA. Then it's transported to the cytoplasm for protein synthesis.
The splicing is mediated by spliceosome that is very similar to ribosome and consists of a huge RNA –
Protein complex. The U6RNA is a part of the spliceosome. The spliceosome stabilizes the enzymatic
reactions that the RNAs cut between the intron-exon boundaries and generates the “Lariat Structure”
or “intron Lariat structure”. Also, the spliceosome can catalyze the second reaction to fuse two exons
together. The introns usually will be discarded but still some introns would be microRNA source or
loan-work RNA source. After splicing, two processes will be done: 5’-end capping and 3’-end tailing
(poly-A tail).
Alternative splicing:
By intron-exon structure, it can be possible to fuse different exons together or combine them to
generate different proteins from one gene. The splice variants (different proteins) come from one
gene, the alternative splicing can overcome by using the alternative promoter that leads to different
splicing or different splice sites. The splice site can be in exon, and then fuse to other exon, or one can
be removed or added exon(s), one can have alternative poly-A site to have pre-mature stop codon,
and mutually exclusive exons. The alternative splicing has a high flexibility for protein synthesis.
RNA editing:
Beside DNA editing by CRISPR-CAS9 method, there is an edition for RNA was discovered. It means that
RNA sequence will be modified after transcription. For example, apo-B gene that has two different
RNA transcriptions in liver and intestine cells. In liver, no editing, apo-B mRNA is generated with
capping and poly-A tail and UAA stop codon (a 100 kD protein). However, in intestine, a specific
modification on one cytosine (C) which is modified into the uracil (u), and this leads a stop codon
mutation (CCA → UAA: stop codon). Then, it's a pre-mature stop codon compared to the liver and has
48 kD protein.
How is it controlled (RNA editing)?
The amino acid sequence is encoded by DNA and has a transcription which a complimentary sequence,
except thymine (T) that is exchanged to uracil (U) in the mRNA, then the exist of guide RNA that can
bind to RNA. However, the guide RNA has differences. These differences sometimes generate gaps,
then by edition can add the additional nucleotides. Finally, it can show the different amino acids. This
is very famous for transposons. By this evidence, it is not possible to guess what the genetic
𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡𝑖𝑜𝑛
information was because due to the RNA editing, everything has been changed (DNA → Pre-
𝑏𝑖𝑛𝑑𝑖𝑛𝑔
→ 𝑒𝑑𝑖𝑡𝑖𝑛𝑔 𝑡𝑟𝑎𝑛𝑠𝑙𝑎𝑡𝑖𝑜𝑛
RNA (Pre-edited RNA) ← guide RNA → edited RNA→ protein).
𝑎𝑙𝑖𝑔𝑚𝑒𝑛𝑡
Modifications on Lysine:
- Acetylation: lysine has an amino group, then after acetylation by HAT, it has been protonated
(charged possibility) at pH=7 that can interact strongly with DNA phosphoryl backbone (due to
the negative charge). This strong interaction between ionic positive and negative charges
between lysine and phosphoryl group of DNAs is very tight and can be elevated by acetylation,
because acetylation removes the positive charge. Then, lysine is not positively charged, and
the interaction is reduced. [Normally: Lys+ ↔ DNA- (interaction, because of amino and
phosphoryl groups); Acetylated: Lys0 ×DNA- (no interaction, because of reducing positive
charge of amino group)]
- Methylation: the methylation on the lysine is the opposite of acetylation and it’s not changing
the charge of lysine, i.e., methylated lysine still has positive charge, because methyl groups are
very small and cannot change the charge too much. However, trimethylated lysine 4 (K9me3)
is associated with gene expression. Because Bromo-/chromodomain proteins can bind and
recognize this histone mark and then it leads to binding other factors and mediates gene
activation in expression. Lysine can be mono-, di-, and trimethylated by KMT (Lysine
Methyltransferase). Also, it can be possible to demethylate by an enzyme called KDM (Lysine
Demethylase). The lysine methylation is not specific for histones, and other factors like
transcription factors (TFs) also can be modified posttranslationally by methylation.
Modifications on Arginine:
Arginine has a positively charged amino acid, and methylation doesn’t have changing on its positive
charge. However, arginine can be mono-, dimethylated. The arginine methylation can be symmetric or
asymmetric. Symmetric dimethylation means each amin groups has methylation, however,
asymmetric methylation is caused on an imine group and an amin group. In this case, the methylation
is done by “PRMT” (Protein Arginine Methyltransferase). The symmetrical methylation is done by
“PRMT type II” and asymmetrical by “PRMT type I”. The monomethylation is catalyzed by “PRMT type
III”.
The PRMT5 and PRMT9 are for symmetrical dimethylation and knock off the genes have severe effects
on the development. It seems that there is no irrelevant process and dimethylation of arginine
symmetrical or asymmetrical have different effects on biochemical pathways.
Histone code:
DNA methylation on CpG islands → repression [mostly caused by environmental effects then leads to
modifications on genes and finally an epigenetically changes]
The histone posttranslational modification (PTM):
➢ Acetylation on lysine (Kac): activation
➢ Phosphorylation on seine (Tph) or threonine (Thph): activation
➢ Methylation on arginine (Rme): activation [different between symmetric and asymmetric]
➢ Methylation on lysine of H3 (H3K4me/ H3K36me/ H3K79me): activation
➢ Methylation on lysine of H3 (H3K9me/ H3K27me) or H4 (H4K20me): repression
➢ Ubiquitination on lysine (Kub): activation / repression
➢ SUMOylation on lysine (Ksu): repression
➢ Isomerized proline (Pisom): activation / repression [it’s not clear].
Remodeling:
Chromatin remodeling complexes (CRCs) are versatile proteins that is also used for gene expression/
suppression. CRC changes the nucleosome positions, modifies histone markers, and adjusts/removes
histones from the DNA, or replaces one histone with a histone variant. It needs ATPs and usually by
moving the DNA around the nucleosomes, works. DNA is wrapped around the nucleosome and a short
push for looping can distorted loop and then loop walks around the nucleosome by using ATPs and
then DNA will shift a little bit around the nucleosome (position shifting). CRC’s can also remove H1
histones from the nucleosome, which are key components of heterochromatin. Depending on the
needs of the cell, certain histone variants can be recruited by CRC’s after adding/erasing the
appropriate histone markers.
One form of remodeling is adjusting the looping of the DNA so one part of the loop encoding the TATA
box is looser and more exposed, increasing transcriptional accessibility.
For chromatin and transcription this remodeling is done by "SWI-SNF Complex". The SWI-SNF complex
uses ATPs and moves far away a long DNA. Then the histone acetyltransferase (HAT) complex can
acetylate the histones, then chromatin will be more open. The SWI-SNF complex recruits histone
deacetylase (HDAC) to allow for moving across the DNA to gene repression. This complex is known for
RNAPII recruitment and opening a site for TBP binding. This also needs ATPs. Another remodeling is
removing one nucleosome from three nucleosomes by SWI-SNF complex and then allows the
transcription.
Histone variants:
One of the levels of regulation is “histone variants”. The typical histones are histone core (H2A, H2B,
H3, and H4). However, there are different histone variants:
- H3.3: for highly expressed genes (associated with transcriptional activation, a marker of active
chromatin)
- CENPA: for kinetochore assembly (microtubule association with centromeres), just in
centromere can be found and important in mitosis.
- H2AX: for DNA repairing, recombination while H2AZ plays roles in gene
expression/chromosome segregation.
- macroH2A: for X-chromosome inactivation in human females (mostly) and transcriptional
repression.
NOTE 1: CENPA is localized in the kinetochores. Research with antibodies’ staining showed that at
metaphase CENPA is associated with kinetochore complexes.
NOTE 2: Entire complexes of activation/ repression can be ubiquitylated and degraded by the
proteasome, depending on the extent of ubiquitination.
NOTE 3: histone variant H3.3 is detected as marker in active chromatin (puffing)
Histone exchange requires chromatin remodeling:
The histone variant needs to exchange, it means in cooperation of variants like H3.3 or H2AZ into the
nucleosome. It means, normally H3 or H2A must be removed, then isoforms must be incorporated.
This also needs Histone Remodeling Complexes (HRCs) that can open the nucleosomes then
incorporate a dimer (H3.3 + H4 = dimer), to the nucleosome by using ATPs.
Three main mechanisms to change chromatin structure:
➢ Chromatin remodeling (needs ATPs): changing nucleosome positions or sliding.
➢ Posttranslational modifications of histones (methylation, acetylation, etc.)
➢ Histone variant exchange (H2AZ → H2A)
NOTE: Bar body just in humans, in fruit flies is double expression.
Cancer pathways: Mechanisms of p53 tumor suppressor and myc protooncogene function, lncRNAs
as regulators of gene expression
The p53 tumor suppressor
One of the most well-known and studied tumor suppressor genes is p53. P53 is normally inhibited by
Mdm2, a ubiquitin ligase. However, certain post translational modifications like phosphorylation lead
to Mdm2 inhibition and tetramerization of p53 at p53 promoter elements, leading to the upregulation
of genes related to cell cycle arrest, apoptosis, DNA repair, senescence, autophagy, and
downregulation of metabolism, angiogenesis, migration, and metastasis.
Although a tumor suppressor gene, p53 is actually an example of haploinsufficiency, where a single
recessive mutation leads to a recessive phenotype. This is because four functional p53 molecules are
needed for tetramerization to occur, the odds of that happening being 20 percent if one dysfunctional
allele is present. Treatment of haploinsufficiency are therapeutic blockers that interfere with Mdm2
binding with p53.
p53 has seven domains of activity.
1. N terminus activation domain (AD1), which activates transcription factors.
2. A second activation domain AD2, important for apoptotic activity.
3. Proline rich domain important for apoptotic activity of p53 by nuclear exportation
4. Central DNA binding domain, which contains one zinc atom and several arginine amino acids.
5. A nuclear localization signaling domain.
6. Homo oligomerization domain
7. A C terminus involved in downregulating the DNA binding of the central domain.
Out of the seven, Mdm2 can interact with serines of the AD1, AD2 and C terminus domains.
To fulfill a particular function, p53 needs to first be phosphorylated at its self-associating DNA binding
domain, as well as interact with other factors. For example, Tip60, an acetyl transferase, often
associates with p53 in different contexts.
When Tip60 acetylates histone H4 at the p21 promoter in association with p53, the cell cycle is
arrested. On the other hand, if Tip60 is acetylated at K120, binding to apoptotic gene promoters is
selectively increased. If MOZ, instead of Tip160, acetylates K120 of p53, p21 induced senescence,
instead of cell death occurs.
Phosphorylation of p53 occurs under a variety of contexts, such as detection of oncogenes (ARF),
double/single strand breaks (ATM/ATR), as well as hypoxia (HIF1alpha). Thus, the outcome of
regulation depends on the concentration of active p53. If a moderate amount of p53 is active, the cell
cycle will be arrested, and repair will occur. However, if a high amount is active, apoptosis will occur.
The Myc oncogene
The oncogene Myc has two domains: a leucine zipper for heterodimerizing and a basic helix loop helix
region for binding to DNA (primarily F-box regions.). Myc has two primary association partners: Mad
and Max. When Myc heterodimerizes with Max, the heterodimer serves as a transcription factor by
binding to enhancer box sequences and at promoters of mitogenic genes. When Myc binds with Mad,
however, a corepressor complex is recruited, which contains a histone deacetylase. Being an
oncogene, Myc is regulated by miRNAs, ubiquitin ligases (such as Fbw7), kinases (like ERK or Src), and
phosphatases (like PP2A). In other words, multiple regulators from different classes modulate the
activity of Myc.
In addition to serving as a transcription factor, Myc also regulates the pause-release of RNA-Pol II by
upregulating phosphorylation of the C-terminal domain. In c-Myc, a member of the Myc family, P-TEFb
(positive transcription elongation factor b), a cyclin dependent kinase is recruited.
Nuclear hormone receptors (HNRs) as a good model system to analyze gene expression:
The hormone receptors are known as a model system to analyze the concepts of gene expression.
There are two types of hormone receptors: (1) membrane – bind receptors, (2) nuclear receptors.
The hormone receptors have four domains: a highly variable domain, a highly conserved DNA binding
domain (zinc finger), a hinge region, and a moderately conserved hormone binding region.
Membrane – bind receptors, or protein hormone receptors are for peptide hormones that cannot cross
and penetrate the cell membrane. This kind of receptors are outside the cell (on cell membrane) and
after peptide binding, they release the signals inside the cell. Usually, they have transmembrane
domain, extracellular domain, and intracellular domains, such as tyrosine-kinase receptor where
growth hormone can bind there. After binding, tyrosine is phosphorylated then cascade cellularly
happened with different mechanisms. Usually there are phosphorylation events for activation of other
kinases such as RAF, RAS, MAPK, ERK, etc. These factors transmit signals into the nucleus. Then,
transcription factors will be activated for gene expression. There are also 7-transmembrane proteins,
there are g-couple receptors that activate cAMP signaling activation protein kinase A, then leading the
signaling into the nucleus.
Nuclear hormone receptors or lipophilic hormone receptors are for lipophilic hormones that can
diffuse through the cell membrane and into the nucleus, binding to transcription factors or activator
proteins there to stimulate transcription. These are classically seen as the “slow” acting hormones.
Because they can enter the membrane, and act inside the cell. The lipophilic hormones and ligase have
nuclear hormone receptors, such as glucocorticoids, vitamins, androgens, estrogen, etc. These
receptors can bind directly to DNA. They have DNA binding domains that are activated by binding to
the ligands.
The nuclear hormone family:
This family can bind to (a) steroids (androgens, estrogens, progestins, glucocorticoids, and
mineralocorticoids), and (b) non-steroids (thyroid hormone, retinoic acid, vitamin D3, prostaglandins).
There are five classes of steroids:
- Androgens (like testosterone) play a role in muscle hypertrophy and the maturation of the
secondary male sex organs, like the maturation of the Wollfian duct into the epididymis and
the vas deferens, as well as the maturation of the genital tubercle and the urogenital sinus into
the secondary male sex organs. There are three peaks of androgen levels: during the second
trimester, the first year of birth, and during/after puberty. Mutations in the androgen receptor
can lead to a female phenotype, even though the genotype is XY.
- Estrogens, in addition to playing a role in female sex determination (such as maturation of the
follicles), also increases the rate of adiposity and calcium absorption. Mutations in the receptor
can lead to forms of breast cancer, which is later discussed.
- Progesterone plays a role in pregnancy maintenance. The endometrium is thickened,
increasing the likelihood that the zygote will attach to the uterine wall. It also helps with bone
growth and serves as a diuretic, maintaining salt and body fluid levels. Progesterone belongs
to a bigger class of hormones known as progestins, some of which serve as a contraceptive by
building a mucal barrier in the cervix.
- Glucocorticoids increase the rate of gluconeogenesis and downregulates the immune system
by upregulating the transcription of inflammatory proteins as well as antagonizing leukocyte
migration. Mutations in the glucocorticoid receptor can lead to Cushing’s syndrome, which is
characterized by abdominal obesity (but not in the extremities), high blood pressure, and poor
healing skin.
- Mineralocorticoids, like aldosterone are responsible for the reuptake of fluids and sodium, as
well as the secretion of potassium. Mutations in the mineralocorticoid receptor, depending on
the nature of the mutation, can lead to either hyperaldosteronism, which is characterized by
hypertension and edema, or hypoaldosteronism, which can lead to hypotension and
hyponatremia, which can be deadly if left unchecked.
Four non-steroids:
- Thyroid hormones are involved in the myelination of neurons, heat generation via signaling to
the hypothalamus, and metabolism via increased sodium pump signaling. Problems in the
pathway can lead to retardation and weight gain.
- Retinoic acids are instrumental in limb and eye development, but also in the maintenance of
white blood cells. Translocations involving this receptor are discussed later.
- Vitamin D3 is responsible for calcium and phosphate absorption, as well as the upregulation
for the innate immune system and the dampening of the adaptive immune system. Defects in
this receptor include rickets and osteoporosis.
- Different prostaglandins of the same family can have antagonizing roles, but prostaglandins
are involved in vasodilation and inflammation, as well as the inhibition of blood platelet
aggregation.
Schematic receptor structure:
A C-terminal binding domain to where these receptors can bind to the indicate the ligand. They have
amino terminus which is flexible and allows gene regulation.
Mechanisms of nuclear hormone receptors (NHRs):
Generally, nuclear hormone receptors are inactive in the cytosol by heat shock proteins. If a hormone
(agonist or antagonist) binds to the protein via its hormone binding domain, the conformation of the
protein changes and heat shock factors disassociate from the protein, allowing it to serve as an
activator or a repressor of gene transcription via histone modifications and association with the RNAPII
holoenzyme, along with the transcription initiation complex. Other hormone receptors are already in
the nucleus.
A modification of this model is the helix-12 domain. When not bound to a hormone, a nuclear
hormone receptor can have a conformation where the helix 12 motif has an affinity for corepressors,
thus allowing the molecule to have repressive activity in the nucleus. On the other hand, when the
ligand binds, the helix 12 motif changes conformation and the receptor increase its affinity for
coactivators. Thus, the same receptor can actively repress and activate the same genes, based on the
conformation of this helix 12 motif.
The RAR-PML fusion protein is the result of a translocation between the 15th and 17th chromosomes.
The tumor suppressor protein PML (promyelocytic leukemia) is fused to the retinoic acid receptor, and
as a result, its activity, being dependent on the retinoic acid receptor, greatly decreases, and a greater
susceptibility to leukemia results. Treatments of all trans retinoic acid in high quantities maintain the
activity of this protein, and only high quantities are sufficient to replace the corepressors with
coactivators.
Other translocations of the RAR protein are not as treatable. For example, the PLZF-RAR translocation
between the 11th and 17th chromosome produces a fusion of the retinoic acid receptor and
promyelocytic leukemia zinc finger tumor suppressor protein. Treatment of high amounts of all trans
retinoic acid leads to only partial coactivator recruitment and corepressor removal, which is
insufficient for the PLZF tumor suppressor to function.
There are deviations from the classical model of hormone receptors, where applying hormone either
represses its activity or stimulates the recruitment of HDACs. Furthermore, even though corepressors
are bound to an NHR when bound to the DNA in the nucleus, those corepressors can have coactivator
function, which depends on the posttranslational modifications that they have.
Hormone agonists activate the hormone receptor by changing the receptor conformation, while
hormone antagonists (artificial in nature) change the receptor conformation into a repressive state.
This can be done by blocking nuclear translocation or allowing the binding of corepressors.
Mamma carcinoma, a type of breast cancer, can be caused by hyperactivation of the estrogen
receptor. A common estrogen antagonist, tamoxifen, is used, and the estrogen receptor enters the
nucleus and represses gene transcription with the help of corepressors via RNAPII holoenzyme
blocking and chromatin modification. However, over time, mitogenic signaling from receptor tyrosine
kinase signaling (like the MAP kinase) pathways override this repressive activity by phosphorylating
corepressors, making the estrogen receptor change to an activator conformation.
Mechanism of “direct” gene regulation by nuclear hormone receptors
There are two distinct models: (1) receptors can bind to HSP factors in cytoplasm, (2) receptors can
bind to DNA without any ligands.
For first model, such as androgen receptor, the ligand binding to hormone leads conformation change
and dissociated by HSP factors, from the receptors. Receptors can be dimerized, and ligand receptor
can bind directly to DNA and allow gene expression.
For second model, such as thyroid hormone receptor, hormone can bind directly to the DNA without
any ligand. There is a possible to repress gene activity, then thyroid hormone is leading the
conformation change and then gene activation. This receptor tends to be heterodimerized by RXR.
Sum up: Model (1): hormone x > receptor (conformation change) > gene (target, e.g., androgen).
Model (2): hormone x > gene1 > gene2 (target, e.g., thyroid hormone)
Crosstalk of nuclear receptors with other transcription factors (no “direct” DNA binding)
The nuclear hormones can inhibit receptors (indirectly downregulate receptor pathways e.g., CREB,
NFκB, Jun/Fos or upregulating other pathways e.g., STAT), such as tyrosine kinase (RTK) activity at level
of Jun/Fos transcription factor which mentioned before as a leucine zipper heterodimer. The nuclear
hormone receptors can repress NFκB pathway or cAMP- protein kinase A (PKA) pathway that is induced
by transmembrane protein. Also, they can activate STAT signaling that is activated by JAK-STAT. all
these pathways are without directly binding to the DNA. Both peptide and lipophilic hormones also
have rapid effects of activation, activating pathways like PLC-PKC, Src-ERK/MAPK, PI3K-PKB/AKT, or
the PKA pathways. The hormone response element (HRE) assay characterizes the nature of a protein
(often a nuclear hormone receptor)’s DNA binding domain. There are non-genomic effects that
premeditatedly by two pathways:
1. High concentration of ligands to activate G-coupled receptors.
2. Nuclear hormone receptors that still acting in the cytoplasm. Small protein remains in the
cytoplasm. For example, lipophilic hormones can interfere with the Src, AKT, cAMP pathways.
Homologies of nuclear hormone receptors
The nuclear hormone receptors are a big family that are highly conserved. The most conserved
domains that is shared by nuclear hormone receptors, is the DNA binding domain (DBD) and second
important structure is conserved, the ligand binding domain (LBD). The variation can be seen only at
the amino parts. For steroids, they have three main conserved parts: ligand binding domain (LBD),
DNA binding domain (DBD), and N-terminal domain (NTD).
Steroidal hormones in insects:
➢ Ecdysone:
This is an important hormone between insects. This hormone is responsible for
metamorphosis (timing) in the insects. Ecdysone is a steroid hormone that can bind to the
nuclear hormone receptor which called it “ecdysone receptor”. Ecdysone interacts with
polytene chromosomes in insects, which develop from the chromosomes of diploid nuclei by
endopolyploidy, or the successive duplication of each chromatid without their segregation.
Drosophila and Diptera insects develop from egg, through different larva stages, then pupa,
and finally provide the adult. For these different steps of development, the ecdysone hormone
where have different triggers that can control different stages in the development from larva
status to pre-pupa and then to the pupa and an adult insect.
Polytene chromosome: interphase chromosomes generated by endopolyploidy in salivary glands of
Diptera.
Polytene chromosomes that are generated by endopolyploidy, can have bands. The interbands of
these polytene / giant chromosomes usually are mentioned as “euchromatins” and bands as
“heterochromatins”.
Puffing
In salivary glands of Diptera larvae, such as Drosophila, there are giant chromosomes called polytene,
that can transcribe many different digestive enzyme mRNAs. Because larva must produce a lot of
enzymes for digestion from its salivary glands (fast eating is the main aim). Therefore, the growth and
cell division are caused by polytene chromosomes. In these glands for fast eating and digestion, all
chromosomes are amplified and aligned exactly on top of each other’s that called “endopolyploidy”
(multimerization of genome about 1000-folds). Each polytene chromosome is seen a 1000-fold copies
and arranged as a similar manner. These giant chromosomes can be seen via the light microscopes.
The interphasic structures of polytene chromosomes have puffing that caused by ecdysone hormone.
The ecdysone binds to the ecdysone receptors that is a transcription factor, then leading to gene
activation. Also, ecdysone is a major regulator of DNA looping out (puffing generation) in the polytene
chromosomes. Depending on the developmental stage, ecdysone can induce puffs in different areas,
but because it doesn’t bring about a constant pattern of puffing in the genome, it is most likely not the
master epigenetic regulator. The puffing means loops of DNA, which are regions of higher transcription
that lack histones and too many transcription factors, chromosome remodeling complexes, etc., that
can be seen via the light microscopes. The puffing is an active transcription site whereas shown very
early by incorporation of UTB of these transcriptional sites.
Polytene chromosomes in plants: Phaseolus vulgaris
Phaseolus vulgaris has large polytene chromosomes were found in the large cells of embryo suspensor
of the legume. These chromosomes are for feeding the future embryo, there is a DNA amplification to
allow very rapid the production of large amounts of proteins to be able for growth supporting of
embryo.
Lamp brush chromosomes: a model for chromosomes looping (DNA looping)
These chromosomes are also visible by light microscopes, there aren’t amplified or endopolyploidy.
They are packed with so many proteins. These interphasic chromosomes can be found in frogs,
salamanders, certain birds, and fishes’ oocytes. These have in the meiosis, very interesting structure
that can be seen a looping out of DNA.
Each of these looping out is an active looping with controlling of CTCFs, cohesin and condensin
proteins. The homologous chromosomes are attached to each other in the central parts and chiasmata
with large lateral loops can be seen. Each loop consists of many genes.
Sum up: the lamp brush chromosomes are generated from the homologous chromosomes, and
chiasmatic regions. They have large lateral DNAs (looped out), and each loop consists of many gene.
Setup: introduction of a cDNA (coding for the nuclear receptor) and HRE/luciferase reporter plasmid
(containing the DNA binding domain) into the target cell genome.
The cDNA plasmid must contain:
- SV40 viral promoter/enhancer/ori (very strong viral-derived promoter, ensuring cDNA
expression
- The expressed cDNA, coding for the nuclear hormone receptor, flanked by a polyadenylation
sequence.
- An ampicillin resistance gene to be selected after cell transfection.
- The reporter plasmid must contain:
- An origin of replication
- An ampicillin resistance gene
- A luciferase reporter gene with a response element-specific enhancer (site of molecule binding
- Procedure: introduce both plasmids into the nucleus of the cell. cDNA will be expressed, and
the receptor will be expressed on the outer membrane of the cell (or in cytosol, depending on
the nature of the receptor). If a hormone is introduced and the receptor binds to the HRE in
the nucleus, luciferase will be expressed, indicating a hormone response element compatible
with the hormone receptor.
Further characterization of the hormone response element can be done via introduction of point
mutations, deletions, and insertions to find out what the DNA binding domain recognizes (palindromic
repeats? Parallel repeats?)
At the end of lecture, Baniahmad proposed an exam question along the lines of the following:
How is gene activation mediated?
(This is an exhaustive answer. It’s meant to give a profile of what both repressed and activated states
would look like, just in case we were asked the opposite question on the exam- how is gene repression
mediated?)
Name the different levels that mediate gene activation.
Before genes are activated, they must be in a repressed state. This repression exists at both the 90 nm
fiber (euchromatin vs heterochromatin) level and at the nucleosome level.
At the nucleosome level, both the CPG islands of DNA and K9 of the H3 histone tail are methylated (by
maintenance and de novo methyl transferases for the DNA and histone methyl transferases for the
histones). Repressive methylations are read by heterochromatic protein 1, which polymerizes with
other copies of itself upon binding, thus making the promoter inaccessible. Histones are also
deacetylated. The combination of proteins responsible for repressive methylation, deacetylation, and
blocking/inhibiting transcription at the TATA box is collectively known as the corepressor complex.
At the 90 nm fiber level, the facultative heterochromatin is held together tightly by condensins as well
as H1 histones, which are responsible for bridging organization between the nucleosome and the 90
nm fiber levels. It is also repressed by nuclear lamins, which generally sequester facultative
heterochromatin near the nuclear membrane region in a transcriptionally inactive state. The chromatin
is isolated into topologically associated domains (TADs), which prevent inappropriate interactions with
extra-TAD chromatin. CTCF insulators mark the boundary of these sites.
Name the factor/family of factors involved in gene activation and give the order of gene activation.
Generally, the first steps of activation are mediated by either a chromatin remodeling complex or by a
histone writer/eraser (although CRC’s can also perform this function).
Chromatin remodeling complexes (like CRC1 or SWI/SNF) can remove H1 histones from the desired area
of activation, making the nucleosomes more accessible to transcriptional machinery. They can also
rotate the DNA looped around the histones, so the TATA box is on the looser end of the double loop.
CRCs also can erase and write histone modifications, which function like histone acetylases (lysine),
histone demethylases (demethylating H3K9me3), histone methyltransferases (methylating H3K4me3
with S-adenosyl methionine as a methyl donor) histone kinases, etc. This not only reduces the overall
attraction interactions between the histones and the DNA but also forces the disassociation of the
multimerized heterochromatic protein readers. In their place, bromo-chromodomain binding proteins
are recruited, which read H3K4me3 and promote transcription of the respective region.
Finally, CRCs can recruit histone variants, which are recruited based on what function the transcribed
gene will provide (CENPA for mitotic spindle assembly, H2AX for DNA repair, macroH2A1 for X
chromosome inactivation, etc.) Chromatin modifications (methylation, for example) are required for
variant exchange to occur.
Some other downstream effects:
Directly methylated cytosines of DNA in CPG islands are demethylated via a TET (ten-eleven
translocation) enzyme, decreasing transcriptional repression.
Increased chromatin accessibility leads to binding of activators to enhancer regions, which interact with
the promoter region and further stabilizes RNA pol II binding, enhancing the rate of transcription. This
can be mediated by either the random interactions within a TAD, or by similar
dimerization/oligomerization sequences at both the promoter and the enhancer.
Increased activation decreases the affinity of silencers for enhancer regions or downregulates them
outright.
Many parts of the pre-existing corepressor complex can be degraded by the proteasome to make way
for components of the coactivator complex.
It is at this point that the RNA polymerase II holoenzyme can bind. However, deviations from classical
models of transcription suggest that RNA pol II don’t go to activated genes but rather the other way
around. Loops of chromatin that are transcriptionally active are brought to transcription factories,
which are RNA pol II- rich sites of transcriptional activity at non-repressive domains of the nucleus.
The order of RNA pol II binding to the promoter is: 1. TATA binding protein to the TATA box with TFIID,
2. TFIIA+B, TFIIE+F+H, 3. mediator protein and RNA pol II, 4. Transcriptional activators at enhancers.
This order of binding mediates transcriptional initiation.
To bridge from initiation to elongation, RNA pol II’s heptapeptide repeats on its serine-rich C terminal
tail domain must be sufficiently phosphorylated so that attenuated pausing is overridden. One common
protein that mediates this is Myc, which after dimerizing with Mad, indirectly phosphorylates the C-
terminal tail.
How would you analyze that Myc inhibits pausing effects of transcription?
Use a coimmunoprecipitation assay, where an antibody against the C-terminal domain of RNA
polymerase II is applied in a Western blot.
You have a new transcription factor, and you don’t know how it works. What would you do to
analyze its activity?
Use ChIP to analyze all sequences it binds to.
Genetics II: Von Eyss Part
Introduction:
• Epigenetics is study of heritable changes in genome function that occur without a change in
DNA sequence. For example, methylation on histones or CpG islands of DNA. A proper
epigenome is responsible for maintaining/establishing a correct cell dedifferentiation state.
The absence of this can lead to cell dedifferentiation, loss of tissue homeostasis and disease.
• Epigenetics is important: because of focusing on (1) transcription regulation (which genes are
“on” or “off”), (2) cell identity, (3) adaption and evolution.
• DNA is not just a sequence of bases; DNA can be modified and covered with proteins which
can be modified, these modifications change DNA accessibility, epigenetic modifications will
determine which genomic regions are transcribed into RNA.
• During the embryotic development, DNA methylation is reset after zygote formation and the
re-established gradually during cell differentiation. When 5mC level in both paternal and
maternal nuclei are analyzed, after unification (zygote formation), the 5mC level in paternal is
reduced rapidly, meanwhile maternal very slowly. They will have very low 5mC level until the
blastocyst level when implantation is happening.
• A proper epigenome is necessary for maintaining / establishing a correct cell differentiation
state. The absence of these can lead to cell de-differentiation, loose of tissue homeostasis and
disease development. ↑DNA methylation: ↓de-differentiation potential: ↑cell specification.
• Adult stem cells are different from embryotic stem cells. During cell division of stem cells, the
differentiation will not be happened. The Division is symmetric and daughter cells are like
mother; that is why one of them can generate another stem cell line again (via “self-renewal”
pathway). Although the newly synthesized DNA strands are unmethylated, DNA
Methyltransferase1 (DNMT1) precisely maintains the DNA methylation status.
• Epigenetics can play important roles in other organisms, for example queen bee can be queen
by effect from environment (royal jelly feeding) that leads silencing the expression of DNA
methyltransferase3 (DNMT3) therefore, it leads to differentiation of a bee into a queen bee.
• Nucleosomes are made of DNA and histone proteins that important for DNA packaging. Due
to the long size of DNA (2 m) that must be organized at the very small nucleus (10 μm), it needs
to be packing in different levels.
• Eukaryotic DNA has different features. Metaphasic chromosomes have a protein scaffold to
which the loops of supercoiled DNA are attached. Chromosome scaffold is a proteinaceous
structure in the shape of a sister chromatid pair, generated when chromosomes are depleted
of histones. DNA of interphase chromatin is negatively supercoiled into independent domains
of ~ 85 kb. Nuclear matrix a network of fibers surrounding and penetrating the nucleus. (naked
DNA > DNA + histones = nucleosomes: “beads-on-a string structure” > nucleosomes + H1
histones: “30 nm fiber structure” > fibers + protein scaffolds: “loops” that extended scaffolds
> “condensed scaffolds” > metaphasic chromosome.
• Chromosomes occupy distinct territories within the nucleus even during the interphase:
There are two ways of chromatin compacting: euchromatin, heterochromatin. This
classification is based on electron microscopy that heterochromatin lies against the nuclear
envelope in patches and is broken up at the site of the nuclear pore. This compaction (more
or less) causes heterochromatin and the euchromatin. The factors which lead these
compactions are histones and histone modifications lead also. Euchromatin means DNA is
accessible and heterochromatin means “NOT”. When a gene wants to be expressed, gene will
change its position in the nucleus. When cell recruited the signals its gene location will be
changed regarding the expression or silencing. The silencing neighborhood is near the nuclear
envelope and expression neighborhood on the specific speckles. There are heterochromatic
(periphery, pericentric chromosomes, nucleoli) and euchromatic regions (nuclear foci like
transcription factories). It is thought that LLPS is responsible for the affinity of the chromatin
to these particular sections in the nucleus, depending on the proteins that bind.
Changes in a gene’s subnuclear location correlate with changes in the gene expression. This
can proof that due to the low DNA methylation, the size of stem cell nucleus is bigger than
differentiated nucleus cells. In the other words, progressive differentiation, and loss of
euchromatin mobility leads to changes in nuclear architecture during differentiation.
• Chromatin fibers can be seen in two levels: “11 nm fibers” or “beads” and “30 nm fibers”. The
beads highly acetylated histones core (H3 and H4) that leads to reduce level of histone H1,
gene transcription possible. The 30 nm fibers are charged positively at N-termini (binding DNA
on neighboring nucleosomes) that leads high level of histone H1 and therefore “no” gene
transcription.
• The structure of nucleosomes is composed from histone proteins (histone core + H1) and
wrapped DNA. Histone structure is an octamer that has twofold symmetry (twice H3, H4, H2A,
H2B). The N-termini of histones (core histones) are important for modifications. They are
happening out around the histone cores. Only Archaea and eukaryotes have histone proteins
in their cells. Histone structures illustrate that they will have completed each other by the
“Handshake” motif. This handshake motif caused by two histones; each histone has a “Histone
folding domain”.
Histone variants: Histone H3 (H3, H3.3 [a transcriptional activity mark], CenpA [a kinetochore
assembly mark]), Histone H2A (H2A, H2AZ [a chromosomal segregation and gene expression
mark], H2AX [DNA repair recombination mark in the yeasts], macroH2A [X-chromosome
transcriptional repression mark]).
All core histones have the structural motif of histone folding that N-terminal tails extend out
of the nucleosome. DNA and histone tails can be modified.
• DNA methylation consists in methyl addition to 5’ position of cytosine at CpG islands (in
mammalians, DNA methylation occurs at CpG dinucleotide, and it is highly symmetric). This
modification correlates with compacted DNA and transcriptional repression. Also, it’s
regulated by intrinsic and external factors. One of famous enzymes for methylation is “DNA
methyltransferase” or DNMT and by S-Adenosylmethionine (SAM).
DNA methylation can act in three ways: (1) maintenance (by DNMT1), (2) de novo (by
DNMT3A, DNMT3B), (3) inactive (by DNMT3)
Due to its symmetry, CpG methylation can be stably propagated during DNA replication by the
maintenance methyltransferase DNMT1. Once established by the de novo methyltransferases
DNMT3A and DNMT3B, the process of DNA methylation maintenance allows inheritance
during cell division.
De novo methylase DNMT3s add a methyl group to an unmethylated target sequence on DNA.
Fully methylated site is a palindromic sequence that is methylated on both strands of DNA and
maintained by DNMT1. TET enzymes oxidize the methyl group to demethylate [TET proteins
use the same reaction mechanism as Jumanji demethylases,
𝑇𝐸𝑇1,2,3+𝐹𝑒(𝐼𝐼)
5𝑚𝐶 → 5ℎ𝑚𝐶].
2 − 𝑂𝐺 + 𝑂2 → 𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 + 𝐶𝑂2
Unmethylated DNA → activity. Methylated DNA (+ HP1, + MeCP2) → silence.
• The act of demethylating DNA has both a passive and an active basis. In the passive pathway,
TET enzymes hydroxylate a methylated cytosine so that it cannot properly interact with
DNMT1. Furthermore, there is also an active pathway. In active demethylation, several
oxidation steps are undergone from 5 hydroxymethyl cytosine to 5-formyl cytosine to 5-
carboxy cytosine. In all these cases, O2 from alpha ketoglutarate is the donor and the rest is
given to succinate.
Afterwards, thymine-DNA glycosylase creates an abasic site, and base excision repair is
undergone via apurinic endonuclease and DNA ligase.
A potential problem to transcribing the gene is the possibility of recognizing promoter-like
sequences downstream of the promoter proper. This is referred to as spurious transcription.
The epigenome has been fashioned in such a way where the gene bodies downstream are
methylated to prevent this.
One of the most common mutations in DNA is due to base deamination. When a methylated
cytosine is demethylated, the intermediate is thymidine, which creates a mismatch against
the guanidine nucleotide. Base excision repair could potentially create a mutation at this
base pair.
NOTE: Housekeeping genes, which themselves have CpG islands, are barely methylated on
the DNA and therefore do not have this problem.
NOTE: DNA methylation can regulate transcription initiation, the chromatin structure itself,
alternative splicing, and transcription elongation.
• Histones regarding their modifications, have three kinds of enzymes. Writers are enzymes that
can add a specific modification on histone tails. Erases are enzymes that can remove a specific
modification on histone tails. Readers are enzymes that can bind the modification and recruit
other steps of pathway (main function).
• Chromosome remodeling complex (CRC) is responsible for different possibilities of chromatin
remodeling that can see: (1) nucleosome sliding, access the gene, (2) histone exchange,
variance, (3) nucleosome eviction, removing histone. Remodeling factor needs energy (ATPs).
Chromosome remodeling factors probably embrace the nucleosome and pull DNA into the
nucleosome.
• Hypersensitive sites are a short region of chromatin detected by its extreme sensitivity to
cleavage by DNase I nucleosome are excluded.
• Histone modifications: acetylation, methylation, ubiquitination, SUMOylation,
phosphorylation.
Three models for effects of posttranslational modifications; model 1: chromatin structural
change, model 2: inhibit binding of negative – acting factor, model 3: recruit positive – acting
factor.
• Histone acetylation is done by histone acetyltransferase (HAT) can recruit transcription factors
for gene activation. Normally it needs cofactors and HAT + Acetyl-CoA can change the amino
acid charge.
Tetrahymena is a unicellular organism with two nuclei, macronucleus (active) and
micronucleus (inactive). For illustrate activity or inactivity of nuclei, people produce
radioactive dNTPs then exposure the microorganism. Then via fluorescence and radioactivity,
they could show MAC has active transcription. They used [3H] sodium acetate for labeling.
Then nuclei were isolated, and histones extracted, and then 2D-SDS-PAGE applied (by
Coomassie and autoradiogram dyes). As results, MAC had banding on both dyes, but MIC only
on Coomassie. It means, only radioactive nucleus had active transcription.
• Histone acetylation by HATs has different functions: (1) loosening of chromatin, (2)
recruitment of additional factors. Acetylated histones can be read by “bromo-domains” of
proteins.
Eukaryotes mRNAs are transcribed by big protein complexes called “RNAPII”. RNAPII needs to
bind to promoter then recruit, then gene transcribing. However, RNAPII cannot bind
everywhere, its regulation is not easily possible. Therefore, first recruitment, then joining
other transcription factors such as TFIID as basal transcription factor.
SWI/SNF or Switch/ Sucrose non-fermenting
(Brg1) is a complex that identified as CRC. This
complex protein was detected a mutation on
digestion of sucrose in yeast. Normally yeast can
grow on glucose and sucrose media, but mutants
can grow on glucose media. SWI/SNF can bind on
two binding sites by bromodomains, then (1)
SAGA via T+A and acetylation, (2) remodeler via
bromodomain and T+A factors can be recruited by
acetylated histones, (3) DNA becomes less
compacted and ready for gene transcription.
In yeast genetic experiments, histone deacetylation was shown to be a mode of epigenetic
repression. In yeast, Sir2 is a histone deacetylase, while Sir3/4 are histone binding proteins
that bind to unacetylated histones to mediate condensation, as well as telomere association,
which is associated with heteronuclear foci.
The reagent 5-fluororotic acid, if processed by URA3 competent yeast, produces 5 fluorouracil,
an agent of DNA damage. As a control, knockouts of yku70, a NHEJ protein, show lower survival
rates in dilution titers in comparison to wild type. Furthermore, knockouts of sir2, a histone
deacetylase, produce a similar phenotype. Sir2 therefore prevents 5-FU from associating with
the DNA due to repression.
• Histone deacetylase (HDACs) can convert acetyl-lysine (acK) to lysine by using H2O and H+.
Histone acetylation/ deacetylation in gene activation and repression:
Acetylation: DNA binding domain (DBD) and other TFs can bind to recruited HATs. Then this
modification leads to switch on and then needs to be switched off by deacetylation.
Question: how to analyze changes in histone acetylation in vivo?
Answer: by using the Chromatin – immunoprecipitation (ChIP) technique: (1) cross – linked
chromatin, (2) isolate and shear chromatin mechanically, (3) add antibody specific for
acetylated N-terminal histone tail, (4) immunoprecipitation, (5) release and purified
immunoprecipitated DNA and assay by PCR.
To obtain the antibodies needed, use a peptide with 10-15 amino acids where the amino acid
of interest is acetylated. Introduce into bloodstream of a rabbit with a carrier (BSA, for
example) that helps efficiently induce an immune response. Additionally, add CFA (crushed
bacteria). For quality check, use an affinity column (1. Enrichment column 2. Depletion
column).
1- Attach peptide antigen to spin column and allow serum to flow so antibody binds. Wash
and elute.
2- In the depletion column, use an affinity column with peptides without acetylation to
ensure purification. Antibody of interest is in flow-through.
To control for change in expression of acetylation, dot blot different histone modifications (K9
vs K27, for example).
• Histone methyltransferase (HMT) causes methylation by using SAM (S-adenosylmethionine)
as methyl donor. Sometimes, same lysine residue can be methylated multiple times:
monomethyl-lysine, dimethyl-lysine, trimethyl-lysine.
Question: how to analyze changes in histone methylation in vivo?
Answer: by using the Chromatin – immunoprecipitation (ChIP) technique: (1) cross – linked
chromatin, (2) isolate and shear chromatin mechanically, (3) add antibody specific for
methylated N-terminal histone tail, (4) immunoprecipitation, (5) release and purified
immunoprecipitated DNA and assay by PCR and finally by using deep-sequencing.
Answer: 35S-labelled HP1 + biotinylated peptide → streptavidin pulldown → SDS-PAGE
NOTE: HATs → acetylation (loosening of chromatin; recruitment of additional factors) =
activation. HMTs → methylation (recruitment of additional factors) = activation or repression.
NOTE: specific domains for binding to methylated lysine (Kme): (1) chromodomains (HP1 >
H3K9me3), (2) Tudor doamains (PHF1 > H3K36me3), (3) plant homeodomains (PHD) (BPTF>
H3K4me3).
NOTE: metagene graphs are used for ChIP-Seq experiments. Metagene is a summarized gene
expression correlates with active promoters based on average. Each pick shows high possibility
of expressing.
• H3K4me3 recruits proteins that facilitate transcription: (1) CHD1 (chromatin remodeling
protein), (2) TAF3 (subunit of TFIID).
• Lysine methylation is reversible by specific enzymes:
(1) FAD-containing oxidases (LSD1/2) → mono-/ dimethylated lysine. For example:
demethylation of H3K4me1/ H3K4me2 by LSD1/2 enzymes.
(2) Jumanji protein (dioxygenase) → mono-/di-/trimethylated lysine. For example:
demethylation of H3K4me3 by Jumonji enzymes (hydroxylases).
•